1. Repositório PUCRS

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 14 (Search time: 0.001 seconds).
Item hits:
Issue DateTitleAuthor(s)
2016The Management of Immune-related Adverse Events Associated with Immune Checkpoint BlockadeAndré Poisl Fay; Raphael Brandao Moreira; Paulo R. S.Nunes Filho; Caroline Albuquerque; Barrios
2016Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênioSTEFANI, STEPHEN; SASSE, ANDRÉ; André Poisl Fay; KIM, HELLEN; ABADI, MARCIA; TEICH, VANESSA; LOPES, GILBERTO
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA; URUN, YUKSEL; CAROL, HALLIE A.; André Poisl Fay; SIGNORETTI, SABINA; KWIATKOWSKI, DAVID J.; MCDERMOTT, DAVID F.; FREEDMAN, MATTHEW; POMERANTZ, MARK M.; CHOUEIRI, TONI K.
2016Quality of life of cancer patients on the wave of immunotherapyRAMOS, FERNANDA B. PRUSKI; André Poisl Fay
2016The Management of Immune-related Adverse Events Associated with Immune Checkpoint BlockadeAndré Poisl Fay; Raphael Brandao Moreira; Paulo R. S.Nunes Filho; Caroline Albuquerque; Barrios
2016Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndré Poisl Fay; DEVELASCO, GUILLERMO; Thai Ho; VAN ALLEN, ELIEZER; Bradley Murray; ALBIGES, LAURENCE; SIGNORETTI, SABINA; A Ari Hakimi; Melissa Stanton; BELLMUNT, JOAQUIM; MCDERMOTT, D. F.; ATKINS, MICHAEL B.; Levi A. Garraway; David Kwiatkowski; CHOUEIRI, TONI K
2016Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapyBELLMUNT, JOAQUIM; ZHOU, CHENSHENG WILLA; MULLANE, STEPHANIE A; WERNER, LILLIAN; TAPLIN, MARY-ELLEN; André Poisl Fay; CHOUEIRI, TONI K; ORSOLA, ANNA; TAKEDA, DAVID Y; HAHN, WILLIAM C; KIM, JAEGIL; SONPAVDE, GURU; BOWDEN, MICHAELA
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA; URUN, YUKSEL; CAROL, HALLIE A.; André Poisl Fay; SIGNORETTI, SABINA; KWIATKOWSKI, DAVID J.; MCDERMOTT, DAVID F.; FREEDMAN, MATTHEW; POMERANTZ, MARK M.; CHOUEIRI, TONI K.
2016Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaMAHONEY, KATHLEEN M.; JACOBUS, SUSANNA; BHATT, RUPAL S.; SONG, JIAXI; CARVO, INGRID; CHENG, SU-CHUN; SIMPSON, MEKAILAH; André Poisl Fay; PUZANOV, IGOR; MICHAELSON, M. DROR; ATKINS, MICHAEL B.; MCDERMOTT, DAVID F.; SIGNORETTI, SABINA; CHOUEIRI, TONI K.
2016Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênioSTEFANI, STEPHEN; SASSE, ANDRÉ; André Poisl Fay; KIM, HELLEN; ABADI, MARCIA; TEICH, VANESSA; LOPES, GILBERTO

Explore